Medford, MA · Founded 2021 · Privately Held (backing)
Developer of an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases. Unravel Biosciences is based in Medford, MA and was founded in 2021. It was valued at $18 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $4.5 million across 2 recorded rounds; the latest was a $500,000 seed round in Feb 2023.
PMV mark · valuation
$18.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$4.5M
Last round
Seed Round
Feb 2023
Cap table — not yet on record
Unravel Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Unravel Biosciences with a free account
·The complete investor list: 12 names
·Watch Unravel Biosciences: the Monday email on marks, rounds and moves
Where does Unravel Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Unravel Biosciences's 2 recorded funding rounds.
